| Literature DB >> 28694399 |
Olgu Hallıoğlu Kılınç, Dilek Giray1, Atıl Bişgin, Sevcan Tuğ Bozdoğan, Derya Karpuz.
Abstract
Familial hypertrophic cardiomyopathy is a genetically heterogeneous disease with variable clinical features that is inherited as autosomal dominant with variable penetrance. Recent developments in genetics of hereditary cardiomyopathy have not only enlightened many points about pathogenesis, but have also provided great benefit to diagnostic approaches of clinicians. Heterozygous mutation of c3691-3692insTTCA in MYBPC3 gene was identified in a pediatric patient with diagnosis of hypertrophic cardiomyopathy at clinic. Hypertrophy was observed in sister and father of the patient in echocardiography screening, and it was subsequently determined that they also had same mutation. This mutation has not previously been defined and reported previously in the literature as cause of hypertrophic cardiomyopathy.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28694399 DOI: 10.5543/tkda.2016.56267
Source DB: PubMed Journal: Turk Kardiyol Dern Ars ISSN: 1016-5169